Fate Therapeutics (FATE) PT Raised to $41 at Wedbush

April 3, 2020 7:16 AM EDT
Get Alerts FATE Hot Sheet
Price: $84.37 -1.94%

Rating Summary:
    15 Buy, 4 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 18 | Down: 11 | New: 8
Trade Now! 
Join SI Premium – FREE

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.

Wedbush analyst David Nierengarten raised the price target on Fate Therapeutics (NASDAQ: FATE) to $41.00 (from $38.00) while maintaining a Outperform rating.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst PT Change